tiprankstipranks
XRF Scientific Limited (AU:XRF)
ASX:XRF
Australian Market
Want to see AU:XRF full AI Analyst Report?

XRF Scientific Limited (XRF) AI Stock Analysis

40 Followers

Top Page

AU:XRF

XRF Scientific Limited

(Sydney:XRF)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
AU$2.00
▲(7.53% Upside)
Action:ReiteratedDate:12/11/25
XRF Scientific Limited's overall stock score reflects strong financial performance with efficient operations and a solid balance sheet. However, mixed technical indicators and moderate valuation suggest limited growth potential without new catalysts. The absence of earnings call insights and corporate events further limits the score.
Positive Factors
Low leverage / solid balance sheet
XRF's very low debt-to-equity (0.073) indicates conservative leverage and strong equity backing. This durable balance sheet supports capital allocation flexibility, resilience through mining cycles, and the ability to fund maintenance, service capabilities or targeted investments without stressing liquidity.
Negative Factors
Slowing revenue growth
Revenue growth turning negative (-1.05%) signals weakening top-line momentum. Over the medium term this can limit reinvestment capacity, reduce operating leverage benefits, and pressure margins unless sales are revitalised via new markets, product expansion, or higher consumables uptake.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / solid balance sheet
XRF's very low debt-to-equity (0.073) indicates conservative leverage and strong equity backing. This durable balance sheet supports capital allocation flexibility, resilience through mining cycles, and the ability to fund maintenance, service capabilities or targeted investments without stressing liquidity.
Read all positive factors

XRF Scientific Limited (XRF) vs. iShares MSCI Australia ETF (EWA)

XRF Scientific Limited Business Overview & Revenue Model

Company Description
XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries in Australia, Canada, and Europe. It operates through Capi...
How the Company Makes Money
XRF Scientific Limited makes money primarily by selling and supporting products and services used in mineral analysis and laboratory testing. Key revenue streams include: (1) Product sales—revenue from the distribution/sale of laboratory and minin...

XRF Scientific Limited Financial Statement Overview

Summary
XRF Scientific Limited exhibits strong profitability and a robust balance sheet, with low leverage and efficient operations. However, the recent decline in revenue growth and free cash flow indicates potential challenges in sustaining growth. The company should focus on revitalizing sales and enhancing cash flow management to maintain its financial health.
Income Statement
75
Positive
Balance Sheet
80
Positive
Cash Flow
70
Positive
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue61.91M59.45M59.84M55.17M40.01M31.29M
Gross Profit30.13M28.79M26.27M22.00M16.46M12.89M
EBITDA16.78M15.63M15.32M13.22M9.44M8.05M
Net Income10.63M10.38M8.89M7.69M6.08M5.13M
Balance Sheet
Total Assets70.03M72.79M68.23M65.55M55.56M48.37M
Cash, Cash Equivalents and Short-Term Investments12.07M12.23M12.05M10.40M6.65M5.26M
Total Debt3.23M4.41M3.38M4.31M3.51M1.44M
Total Liabilities8.67M12.62M12.69M15.97M12.21M9.27M
Stockholders Equity61.36M60.17M54.89M49.25M43.48M39.10M
Cash Flow
Free Cash Flow10.17M8.39M6.45M7.63M2.63M3.86M
Operating Cash Flow12.10M10.14M8.09M8.42M3.15M4.51M
Investing Cash Flow-1.77M-2.21M-1.64M-782.43K-1.11M-652.62K
Financing Cash Flow-6.40M-7.75M-4.80M-3.88M-648.95K-2.24M

XRF Scientific Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1.86
Price Trends
50DMA
1.80
Positive
100DMA
1.92
Negative
200DMA
1.99
Negative
Market Momentum
MACD
0.03
Negative
RSI
57.03
Neutral
STOCH
83.55
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:XRF, the sentiment is Neutral. The current price of 1.86 is above the 20-day moving average (MA) of 1.73, above the 50-day MA of 1.80, and below the 200-day MA of 1.99, indicating a neutral trend. The MACD of 0.03 indicates Negative momentum. The RSI at 57.03 is Neutral, neither overbought nor oversold. The STOCH value of 83.55 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:XRF.

XRF Scientific Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
AU$259.62M13.9217.50%2.31%3.02%11.08%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
54
Neutral
AU$151.33M4.742.67%593.88%80.32%
48
Neutral
AU$245.44M-58.52-4.01%77.84%
43
Neutral
AU$85.80M-10.68-9.37%-119.82%
42
Neutral
AU$420.00M-6.45-117.09%-432.83%
42
Neutral
AU$851.20M-1.53-63.71%-1091.18%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:XRF
XRF Scientific Limited
1.82
0.31
21.00%
AU:MTM
Mt Monger Resources Ltd.
0.57
0.36
171.43%
AU:DTR
Dateline Resources Limited
0.23
0.20
650.00%
AU:KAU
Kaiser Reef Ltd
0.25
0.08
47.06%
AU:GG8
Labyrinth Resources Limited
0.34
-0.11
-24.72%
AU:PTN
Kin Mining NL
0.06
>-0.01
-3.33%

XRF Scientific Limited Corporate Events

XRF Scientific lifts quarterly profit on strong international demand and product momentum
Apr 14, 2026
XRF Scientific reported a strong March 2026 quarter, with revenue rising 13.8% to $15.8 million and profit before tax up 10.7% to $3.7 million, driven primarily by international sales growth in Asia across all divisions. Year-to-date revenue for t...
XRF Scientific Seeks ASX Quotation for New Employee Incentive Shares
Mar 4, 2026
XRF Scientific Limited has applied for quotation on the ASX of 47,712 ordinary fully paid shares, with an issue date of 4 March 2026. The new securities have been issued under the company’s employee incentive scheme, indicating ongoing use o...
XRF Scientific Sets Up Direct Operation in India to Target Long-Term Growth
Jan 27, 2026
XRF Scientific will establish a new office in India, marking a strategic shift from a distributor-led model to a direct presence in what it views as a key long-term growth market driven by mining and industrial demand. The Indian operation, to beg...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 11, 2025